A
·
B
·
C
·
D
·
E
·
F
·
G
·
H
·
I
·
J
·
K
·
L
·
M
·
N
·
O
·
P
·
Q
·
R
·
S
·
T
·
U
·
V
·
W
·
X
·
Y
·
Z
·
·

Directory Results for EFFECTIVE FEBRUARY 1, 2022 THROUGH JUNE 30, 2022 OR WHILE FUNDING LASTS to Effective February 10, 2015, MusclePharm Corporation (the Company) agreed to issue an aggregate of 170,000 shares of its